Cirrhosis Clinical Trial
Official title:
Improving Performance of Paracentesis in Medical Residency Training
The investigators hypothesize that there is significant variability in management of
patients with ascites despite guidelines provided by the American Association for the Study
of Liver Diseases, the professional organization most involved with management of liver
patients. This variability may be attributable to knowledge deficits, skill limitations, or
reflect systems-issues that limit the ability of a care provider to implement the clinical
guidelines (time constraints, inadequate supervision, availability of appropriate equipment,
and obtaining consent for non-emergent procedures). This variability does a disservice to
the patients being treated, and results in trainee development of habits that are not
evidence based. There are simple teaching tools available that may improve learning and
retention of evidence based practice. Using these tools should result in more consistent
appropriate patient care, improve patient outcomes, and provide better education to our
trainees.
The purpose of this study is threefold: 1. To improve medical house-staff's technical
performance of and comfort level with paracentesis; 2. To improve adherence to professional
organization guidelines and to determine if this in fact improves clinical outcomes; 3. To
evaluate efficacy of three teaching interventions in inpatient medicine trainee rotations.
Since 2004 the American Association for the Study of Liver Disease (AASLD) has
well-established guidelines for management of liver failure patients that is based on expert
review of current literature. These guidelines address the initial evaluation of patients
admitted to the hospital with complications of their liver disease, including patients with
abdominal distention from fluid accumulation. In many cases, evaluation of this
intraabdominal fluid, or ascites, performed using paracentesis, a procedure in which fluid
is withdrawn from the abdomen and sent for laboratory analysis, is indicated, and the
results of which will guide further treatment. Despite these guidelines, there remains
significant variability in practice among inpatient providers.
The study will begin with a chart review to identify compliance with, and barriers to,
evidence-based recommendations. A baseline survey of house-staff in the internal medicine
department will be used to identify knowledge base and perceived barriers to implementation
of best practices as defined by AASLD. The house-staff will subsequently be divided into
three intervention groups for administration and evaluation of different teaching tools. A
control group will have internet access to AASLD guidelines and undergo teaching that is
already provided by the residency program. The second group will receive the baseline
teaching, but also receive a pocket-card outlining recommendations and participate in a
short, dedicated lecture to reinforce the guidelines. The third group will receive the
pocket card, lecture, and a pager number to call for individual education at the time that
cases arise. The groups will be followed for a period of six months, after which they will
participate in an exit survey for reassessment of knowledge and perceived barriers, and a
chart review will be conducted for comparison of data.
The primary outcome will be subjective improvement in practice based on survey results.
Secondary outcomes will be measurement of actual and perceived benefit of pocket card,
lecture, and individual education, determined by knowledge based questions on the survey,
and improvement in patient clinical outcomes based on chart review noting particularly
30-day readmission rate and 90-day mortality.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |